|
|
.
See Category: Diseases of the eye and adnexa
See Header: Cataract secondary to ocular disorders (inflammatory)
ICD-10 (CM) Code and Descriptor
|
H26.222 |
Cataract secondary to ocular disorders (degenerative) (inflammatory), left eye
|
H26222 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 12 |
ICD10
Position 13 |
| 29.31%
|
33.62%
|
13.79%
|
6.90%
|
4.31%
|
3.45%
|
3.45%
|
0.86%
|
0.86%
|
2.59%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H26.222*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
16
|
40
|
|
V2632
|
POST CHMBR INTRAOCULAR LENS |
16
|
16
|
|
J0171
|
ADRENALIN EPINEPHRINE INJECT |
13
|
58
|
|
66984
|
XCAPSL CTRC RMVL W/O ECP |
11
|
11
|
|
66982
|
XCAPSL CTRC RMVL CPLX WO ECP |
10
|
10
|
|
J3010
|
FENTANYL CITRATE INJECTION |
7
|
25
|
|
J7120
|
RINGERS LACTATE INFUSION |
7
|
8
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
5
|
45
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
5
|
5
|
|
82962
|
GLUCOSE BLOOD TEST |
4
|
4
|
|
C1780
|
LENS, INTRAOCULAR (NEW TECH) |
4
|
4
|
|
J2001
|
LIDOCAINE INJECTION |
4
|
16
|
|
92136
|
OPHTHALMIC BIOMETRY |
3
|
3
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
3
|
3
|
|
G0467
|
FQHC VISIT, ESTAB PT |
3
|
3
|
|
84132
|
ASSAY OF SERUM POTASSIUM |
2
|
2
|
|
J7040
|
NORMAL SALINE SOLUTION INFUS |
2
|
2
|
|
J2405
|
ONDANSETRON HCL INJECTION |
2
|
8
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2
|
2
|
|
J3370
|
VANCOMYCIN HCL INJECTION |
2
|
2
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H26.222 related to the following DRG Codes:
124-125
|
